RAMSELPHARMA
ActiveSummary
RAMSELPHARMA has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €637,252 and a net result of €124,952. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 80% of 12,519 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Highest result from 2018 to 2025net €124,952 ▲24.9%
Operating result €205,486, net result €124,952, both a record.
04-08
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format · 4 days late
2024
03-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
29-06
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
30-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
06-07
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
01-07
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
02-07
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
27-06
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
20-06
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 35 annual accounts filed, the latest 10 are here; all 35 are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.